glp 1 drugs and cancer GLP-1 cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like semaglutide were up to 50% less likely GLP-1s appear to cut cancer

Selank Selank is a synthetic peptide analog of the endogenous tetrapeptide tuftsin

Joint surface lesions in the knee treated with an acellular aragonite-based scaffold: a 3-year follow-up case series

There is no consistent, reproducible body of evidence [supporting increased suicidal ideation]

Berberine Attenuates Choline-Induced Atherosclerosis by Inhibiting Trimethylamine and Trimethylamine-N-Oxide Production via Manipulating the Gut Microbiome

This distinction has real biological consequences: a localized, self-limiting signal and a persistent, body-wide one are not merely different doses of the same thing, and the animal literature on localized IGF-1 expression illustrates why